drugset / Trial / NCT00354510

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

NCT00354510 ↗

Phase 2 Completed 190 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the clinical efficacy of 3% (w/w) GW842470X cream applied to involved skin of adult patients with moderate atopic dermatitis using the Eczema Area Severity Index (EASI) assessment of disease severity and to investigate the safety of and tolerability of 3% GW842470X cream on diseased skin of adult patients.

Timeline

Start
2006-03
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AWD-12-281 Small molecule 3 % Topical

Indications